dapsone has been researched along with Genetic Predisposition in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with aggressive bladder cancer had a similar distribution but significantly lower mean value (p < 0." | 5.29 | Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. ( Adedoyin, A; Branch, RA; Fleming, CM; Kaisary, A; Persad, R; Porter, J; Smith, P; Wilkinson, GR, 1994) |
| "We performed a genomewide association study involving 872 participants who had received dapsone as part of multidrug therapy for leprosy (39 participants with the dapsone hypersensitivity syndrome and 833 controls), using log-additive tests of single-nucleotide polymorphisms (SNPs) and imputed HLA molecules." | 3.79 | HLA-B*13:01 and the dapsone hypersensitivity syndrome. ( Bao, FF; Bei, JX; Chen, MF; Chen, SL; Chen, SM; Chen, XC; Chu, TS; de Bakker, PI; Foo, JN; Fu, XA; Huang, JX; Huang, ZM; Irwanto, A; Jia, XM; Li, JH; Li, JL; Li, M; Li, Y; Li, Z; Liany, H; Liu, DC; Liu, H; Liu, HX; Liu, J; Liu, JJ; Liu, YX; Liu, ZS; Long, H; Low, HQ; Lu, XM; Ma, SS; Ning, Y; Niu, GY; Pulit, SL; Shen, JP; Shi, BQ; Sun, YH; Tian, HQ; Wang, C; Wang, H; Wang, JQ; Wang, LM; Wang, N; Wang, XD; Wang, ZZ; Wei, ZH; Wu, WB; Xiao, P; Xiong, L; Yan, LB; Yang, J; Yang, Q; Yang, RD; You, JB; Yu, DB; Yu, GQ; Yu, XL; Yu, YX; Zeng, YX; Zhang, FR; Zhang, GC; Zhang, LH; Zhang, ZX; Zheng, ZY; Zhou, GZ; Zhou, Y, 2013) |
| "DH is associated to a gluten enteropathy and its physiopathology is better known." | 2.47 | [Dermatitis herpetiformis: a review]. ( Ingen-Housz-Oro, S, 2011) |
| "Dermatitis herpetiformis is a subepidermal autoimmune acquired blistering skin disorder that is associated with intestinal gluten sensitivity." | 1.36 | [Dermatitis herpetiformis]. ( Lioger, B; Machet, L; Machet, MC, 2010) |
| "Patients with aggressive bladder cancer had a similar distribution but significantly lower mean value (p < 0." | 1.29 | Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer. ( Adedoyin, A; Branch, RA; Fleming, CM; Kaisary, A; Persad, R; Porter, J; Smith, P; Wilkinson, GR, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schumacher, S | 1 |
| Pieringer, H | 1 |
| Chen, WT | 1 |
| Wang, CW | 1 |
| Lu, CW | 1 |
| Chen, CB | 1 |
| Lee, HE | 1 |
| Hung, SI | 1 |
| Choon, SE | 1 |
| Yang, CH | 1 |
| Liu, MT | 1 |
| Chen, TJ | 1 |
| Fan, WL | 1 |
| Su, SC | 1 |
| Lin, YY | 1 |
| Chang, YC | 1 |
| Chung, WH | 1 |
| Zhang, FR | 1 |
| Liu, H | 1 |
| Irwanto, A | 1 |
| Fu, XA | 1 |
| Li, Y | 1 |
| Yu, GQ | 1 |
| Yu, YX | 1 |
| Chen, MF | 1 |
| Low, HQ | 1 |
| Li, JH | 1 |
| Bao, FF | 1 |
| Foo, JN | 1 |
| Bei, JX | 1 |
| Jia, XM | 1 |
| Liu, J | 2 |
| Liany, H | 1 |
| Wang, N | 1 |
| Niu, GY | 1 |
| Wang, ZZ | 1 |
| Shi, BQ | 1 |
| Tian, HQ | 1 |
| Liu, HX | 1 |
| Ma, SS | 1 |
| Zhou, Y | 1 |
| You, JB | 1 |
| Yang, Q | 1 |
| Wang, C | 1 |
| Chu, TS | 1 |
| Liu, DC | 1 |
| Yu, XL | 1 |
| Sun, YH | 1 |
| Ning, Y | 1 |
| Wei, ZH | 1 |
| Chen, SL | 1 |
| Chen, XC | 1 |
| Zhang, ZX | 1 |
| Liu, YX | 1 |
| Pulit, SL | 1 |
| Wu, WB | 1 |
| Zheng, ZY | 1 |
| Yang, RD | 1 |
| Long, H | 1 |
| Liu, ZS | 1 |
| Wang, JQ | 1 |
| Li, M | 1 |
| Zhang, LH | 1 |
| Wang, H | 1 |
| Wang, LM | 1 |
| Xiao, P | 1 |
| Li, JL | 1 |
| Huang, ZM | 1 |
| Huang, JX | 1 |
| Li, Z | 1 |
| Xiong, L | 1 |
| Yang, J | 1 |
| Wang, XD | 1 |
| Yu, DB | 1 |
| Lu, XM | 1 |
| Zhou, GZ | 1 |
| Yan, LB | 1 |
| Shen, JP | 1 |
| Zhang, GC | 1 |
| Zeng, YX | 1 |
| de Bakker, PI | 1 |
| Chen, SM | 1 |
| Liu, JJ | 1 |
| Lioger, B | 1 |
| Machet, MC | 1 |
| Machet, L | 1 |
| Ingen-Housz-Oro, S | 1 |
| Sekar, B | 1 |
| Arunagiri, K | 1 |
| Kumar, BN | 1 |
| Narayanan, S | 1 |
| Menaka, K | 1 |
| Oommen, PK | 1 |
| Merk, HF | 1 |
| Fleming, CM | 1 |
| Persad, R | 1 |
| Kaisary, A | 1 |
| Smith, P | 1 |
| Adedoyin, A | 1 |
| Porter, J | 1 |
| Wilkinson, GR | 1 |
| Branch, RA | 1 |
| Zone, JJ | 1 |
| Meyer, LJ | 1 |
4 reviews available for dapsone and Genetic Predisposition
| Article | Year |
|---|---|
Relapsing polychondritis: a chameleon among orphan diseases.
Topics: Antirheumatic Agents; Biological Products; Dapsone; Diagnosis, Differential; Genetic Predisposition | 2017 |
[Dermatitis herpetiformis: a review].
Topics: Adult; Animals; Autoantibodies; Celiac Disease; Child; Combined Modality Therapy; Complement C3; Dap | 2011 |
[Pharmacogenetics: Important aspects for dermatology].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Dapsone; Dermatology; Drug Eruptions; Fluorou | 2005 |
Dermatitis herpetiformis.
Topics: Autoantibodies; Biopsy; Celiac Disease; Chemotaxis, Leukocyte; Dapsone; Dermatitis Herpetiformis; Ge | 1989 |
5 other studies available for dapsone and Genetic Predisposition
| Article | Year |
|---|---|
The Function of HLA-B*13:01 Involved in the Pathomechanism of Dapsone-Induced Severe Cutaneous Adverse Reactions.
Topics: Adult; Aged, 80 and over; Alleles; Antigens, Differentiation, T-Lymphocyte; Coculture Techniques; Da | 2018 |
HLA-B*13:01 and the dapsone hypersensitivity syndrome.
Topics: Adult; Dapsone; Drug Hypersensitivity; Drug Therapy, Combination; Female; Genetic Predisposition to | 2013 |
[Dermatitis herpetiformis].
Topics: Biopsy; Causality; Combined Modality Therapy; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differen | 2010 |
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Topics: Animals; Bacterial Proteins; Biopsy; Clofazimine; Cross-Sectional Studies; Dapsone; Dihydropteroate | 2011 |
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancer.
Topics: Case-Control Studies; Dapsone; Genetic Predisposition to Disease; Humans; Hydroxylation; Inactivatio | 1994 |